Health Pfizer Beats Q3 Estimates and Raises 2026 Outlook Despite COVID Revenue Decline November 3, 2026 Pfizer delivered better-than-expected third-quarter results on Tuesday, prompting the pharmaceutical giant to raise its full-year 2026 outlook even as demand for its COVID-19 products continues to wane. The company reported…
Business Merck Reports Strong Q2 Growth Driven by Oncology and Animal Health; FDA Approves First Oral PCSK9 Inhibitor August 4, 2026 Merck & Co., Inc. delivered second-quarter 2026 results that exceeded Wall Street expectations, posting revenue of $16.6 billion and demonstrating continued strength across its oncology portfolio and animal health division.…